The price of Vera Therapeutics Inc (NASDAQ: VERA) closed at $37.52 in the last session, up 0.29% from day before closing price of $37.41. In other words, the price has increased by $+0.11 from its previous closing price. On the day, 936415 shares were traded.
Ratios:
We take a closer look at VERA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.42 and its Current Ratio is at 7.42. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On December 18, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on December 18, 2023, with a $29 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 03 ’24 when Grant Sean sold 99,828 shares for $39.61 per share. The transaction valued at 3,954,516 led to the insider holds 66,337 shares of the business.
Grant Sean sold 18,649 shares of VERA for $735,205 on Apr 03 ’24. The CHIEF FINANCIAL OFFICER now owns 0 shares after completing the transaction at $39.42 per share. On Mar 25 ’24, another insider, Katabi Maha, who serves as the Director of the company, sold 340,000 shares for $40.50 each. As a result, the insider received 13,770,000 and left with 2,793,987 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2.04B and an Enterprise Value of 1.93B.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $50.78, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 42.05, while the 200-Day Moving Average is calculated to be 21.94.
Shares Statistics:
According to the various share statistics, VERA traded on average about 1.31M shares per day over the past 3-months and 798.69k shares per day over the past 10 days. A total of 44.45M shares are outstanding, with a floating share count of 39.27M. Insiders hold about 26.88% of the company’s shares, while institutions hold 61.61% stake in the company. Shares short for VERA as of Mar 15, 2024 were 6.24M with a Short Ratio of 4.77, compared to 6.77M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.62% and a Short% of Float of 14.54%.
Earnings Estimates
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.53 for the current quarter, with a high estimate of -$0.46 and a low estimate of -$0.6, while EPS last year was -$0.8. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.47 and low estimates of -$0.65.
Analysts are recommending an EPS of between -$1.98 and -$2.62 for the fiscal current year, implying an average EPS of -$2.16. EPS for the following year is -$2.32, with 6 analysts recommending between -$1.85 and -$3.17.
